Target intelligence / Profile preview

ADGRB3 divergent transcript (ADGRB3-DT)

Target
ADGRB3-DT
Molecular classification
Long noncoding RNA (lncRNA), Other (not a receptor, enzyme, ion channel, transporter, or transcription factor)
01

Overview

ADGRB3 divergent transcript (ADGRB3-DT) is a human long noncoding RNA gene located at the ADGRB3 locus on chromosome 6. It does not encode a protein and is not implicated as a therapeutic target. While lncRNAs can have diverse regulatory functions in gene expression, chromatin remodeling, and cellular processes, specific functions and disease associations for ADGRB3-DT remain unclear. It has been identified in transcriptomic studies, including differential expression analyses in neuropsychiatric disease such as opioid use disorder, but there is no evidence for direct biological or clinical relevance at this time.

Other names
AL391807.1RP3-525N10.2
02

Mechanism of action

Not applicable. No drugs target ADGRB3-DT, so no mechanism of action is defined.

03

Biological functions

Not well-characterizedNo documented role in signal transduction, apoptosis, immune response, or cell cycle regulationPotential regulatory roles in gene expression or chromatin structure (as a general lncRNA)
04

Disease associations

Cancer: not establishedInflammation: not establishedNeurodegenerative disease: not establishedCardiovascular disease: not establishedOpioid use disorder: exploratory

Beyond the preview

Go deeper on ADGRB3 divergent transcript (ADGRB3-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ADGRB3 divergent transcript (ADGRB3-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call